Fulvant (Fulvestrant Injection)

Fulvant (Fulvestrant Injection 250 mg)

Fulvant (Fulvestrant Injection) is a cancer drug. It is prescribed to treat breast (estrogen-dependent) cancer in women going through menopause. It is available as an injection. Fulvestrant which contains Fulvant is Selective Estrogen Receptor Degrader (SERD). Breastfeeding is not recommended. To avoid further complications, the doctor should be informed about the risks and benefits of using these injections (before taking them).

Pharmacodynamics

Fulvant (Fulvestrant Injection) is an anti-estrogen. It acts as an estrogen receptor (ER) antagonist and a selective estrogen receptor degrader (SERD). It binds to estrogen receptors. Fulvant make them more hydrophobic, which in turn makes the receptors unstable and wobbly. Hence, it carries out the normal process in the cell to break it down.

Usage of Medicine

Fulvestrant injection 250 mg is a prescription drug. It is used to treat breast cancer in women who are going through menopause. The dosage strength and duration will be determined by the doctor according to your medical condition and medical history. It is recommended that you tell your doctor the details of any medication (which you are already taking) to make it more effective. This injection is also not recommended for use in women during pregnancy.

Side Effects

The side effects of injecting Fulvestrant Injection are listed below. It is important to consult a doctor if this / other side effect occurs.

• Headache
• Fever
• Vomiting
• Diarrhea
• Nausea
• Allergic reaction
• Urine infection
• Weight loss
• Tiredness
• Itching
• Skin rash
• Difficulty in breathing

Interactions

All drugs interact differently from person to person. Therefore it is advisable to consult a doctor to discuss this before taking any new drugs.

Contraindication

This injection is not indicated for use in patients who are allergic to fulvestrant.